Agricultural Biologicals Market
授權報價
| Single User | $4,799 USD |
| Multi User | $7,999 USD |
| Enterprise / Global Site Licence | $17,999 USD |
完整報告名稱與涵蓋範圍
Agricultural Biologicals Market by Type of Product, Source of Product, Mode of Application, Type of Crop Treated, Geographical Regions and Leading Players – Trends and Forecast Till 2035
報告摘要
AGRICULTURAL BIOLOGICALS MARKET: OVERVIEW
As per Roots Analysis, the global agricultural biologicals market is estimated to grow from USD 18.27 billion in the current year to USD 43.53 billion by 2035, registering a CAGR of 10.1% across the forecast period.
Agricultural Biologicals Market: Growth and Trends
Agricultural biologicals, such as biopesticides, biofertilizers, and biostimulants are naturally derived crop protection and nutrition products that enhance crop yield and soil health through biological mechanisms. Over the past decade, agricultural biologicals have evolved from a niche solution to a mainstream component of integrated crop management, driven by climate variability, soil degradation, and stricter chemical residue regulations
Additionally, rising global food demand, water scarcity, increasing pest resistance, and stricter regulations on synthetic agrochemicals are driving the adoption of biological alternatives that improve productivity while supporting regulatory compliance. Agencies such as the Food and Agriculture Organization (FAO), the US Environmental Protection Agency (EPA), the European Food Safety Authority (EFSA) and the Indian Council of Agricultural Research (ICAR) have reinforced the role of biological crop inputs in national food-security and soil-health strategies, creating favorable conditions for commercial adoption.
Multinational agrochemical manufacturers and specialized biological product developers are expanding their biological portfolios. For instance, BASF's completed acquisition of AgBiTech to strengthen its biological insect-control offering. Meanwhile, IPL Biologicals' third manufacturing plant in Gujarat increased production capacity to 7,000 KL per year, and Syngenta's continued build-out of natural-compound and microbial-strain capabilities. These developments signal that biologicals are being treated as a structural, long-term category rather than an experimental sideline. These initiatives indicate a shift with direct implications for distribution partners, formulation logistics and channel economics.
Growth Drivers: Factors Fueling Market Expansion
Agricultural biologicals market growth is being driven by increasing regulatory restrictions on synthetic agrochemicals to promote environmentally friendly and sustainable farming, which is accelerating adoption of biological crop protection. Additionally, growing demand for residue-free produce has further shifted farmers' focus toward agricultural biologicals. Further, the push toward sustainable and regenerative agriculture, reinforced by FAO estimates that roughly 1.7 billion people live in regions affected by human-induced land degradation, is widening the addressable base for biofertilizers and biostimulants. Continued advances in microbial strain discovery, fermentation technology and formulation stability are improving field consistency, a long-standing barrier to grower confidence.
Market Challenges: Critical Barriers Hindering Progress
Although agricultural biologicals are being adopted on a large scale, the market still witnesses several challenges that need to be addressed. Field performance for biological products can vary with climatic conditions, soil type, and crop variety. These factors may limit farmer confidence relative to standardized synthetic chemistries. Regulatory treatment is also inconsistent: while biopesticides go through defined pesticide-registration pathways, biostimulants largely fall outside formal EPA registration in the US and face fragmented rules across other geographies, allowing products with unverified efficacy claims to enter the market and creating uneven competitive conditions for compliant developers.
Agricultural Biologicals Market: Key Insights
The report delves into the current state of the agricultural biologicals market and identifies potential growth opportunities for distribution partners, channel intermediaries, and agri-input retailers. Some key findings include:
• Storage and formulation stability differ meaningfully by source of product: plant-extract biologicals generally face fewer storage and viability constraints than microbial formulations, which require distributors to maintain differentiated handling protocols across their portfolio rather than a single cold-chain standard.
• The forecast shift toward seed treatments as the fastest-growing application mode is opening a distinct channel opportunity: companies and distributors that establish partnerships with seed manufacturers and integrated crop-solution providers are positioned to capture early-stage adoption before it reaches broad-acre foliar and soil channels.
• Regulatory fragmentation for biostimulants, which largely fall outside formal EPA pesticide registration in the US and face inconsistent frameworks elsewhere, is allowing products with unverified efficacy claims into the market; distributors that can validate and stand behind formulation quality have a clear differentiation lever over price-only competitors.
• Capacity build-out in Asia-Pacific, exemplified by IPL Biologicals' expanded manufacturing plant in Gujarat, is increasing the need for regional distribution and logistics partners capable of navigating local regulatory pathways and last-mile delivery into fragmented smallholder markets.
• Consolidation among large agrochemical majors, such as BASF's acquisition of AgBiTech, is raising barriers to entry for smaller regional developers while simultaneously creating openings for niche distributors with crop-specific or geography-specific expertise that larger, generalist channel players cannot easily replicate.
• In high-value horticultural segments such as fruits and nuts, growers increasingly expect value-added services, including on-farm trials and export-certification assistance, alongside product supply, indicating that distributors in this space are competing on technical support rather than logistics cost alone.
• Government-backed soil-health programs, such as ICAR-CRIDA's Save the Field Campaign in India, are directly channelling farmer demand toward biofertilizers and biological inputs, giving distributors aligned with public-sector extension programs a durable, policy-supported demand base in cereals and pulses.
Recent Deal Activity Signalling Investor Momentum
• Capacity Expansion: IPL Biologicals' new manufacturing plant in Vadodara, Gujarat lifts annual output to 7,000 KL / year, a direct proxy for sustained multi-year volume growth in the Asia-Pacific supply base.
• M&A Activity: BASF Agricultural Solutions' completed acquisition of AgBiTech extends its biological insect-control portfolio, signaling continued consolidation among originator-scale players.
• Regulatory Momentum: BioPrime AgriSolutions' approval for 20 biostimulant formulations from India's Ministry of Agriculture illustrates accelerating regulatory clarity in key emerging markets.
• R&D Deepening: Syngenta's acquisition of a natural-compound and genetic-strain repository from Novartis reflects sustained investment in proprietary microbial and botanical discovery platforms.
Agricultural Biologicals Market Segments
The market sizing and opportunity analysis has been segmented across the following parameters:
By Type of Product
• Biopesticides / Biocontrol
• Biofertilizers
• Biostimulants
By Source of Product
• Microbes
• Plant Extracts
• Other Sources
By Mode of Application
• Foliar Sprays
• Seed Treatments
• Soil Treatments
• Other Application Methods
By Type of Crop Treated
• Cereals and Pulses
• Fruits and Nuts
• Oilseeds
• Green Fodder, Vegetables and Tubers
• Industrial Crops, Textile Crops and Others
By Geographical Regions
• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia-Pacific
• Middle East and North Africa
• Saudi Arabia
• UAE
• Latin America
• Brazil
• Argentina
• Rest of Latin America
Agricultural Biologicals Market: Key Segments
Biopesticides and Biocontrol Leads the Market
Biopesticides and biocontrol solutions currently account for the largest share of overall market share. This highest share is supported by the high economic value of crop protection and yield preservation. Further, the tightening residue regulations that favor biological alternatives to synthetic pesticides has further driving this segment growth.
In the coming years, Biofertilizers are projected to register the higher CAGR during the forecast period. This lucrative growth is largely because growers are increasingly prioritizing long-term soil health and nutrient-use efficiency, which is likely to increase the demand for biofertilizers. Further, the rising fertilizer costs and government-backed regenerative agriculture programs have supported the growth of biofertilizers segment.
Microbial Products Dominate the Market
Based on Roots Analysis market report, microbial products capture the highest market share. This highest share reflects their broad applicability across protection, fertilization and biostimulation, and their established track record on efficacy and scalability.
In the long run, plant extracts are expected to grow at a comparatively higher CAGR during the forecast period. This growth is aided by favorable storage stability and regulatory profiles relative to microbial formulations.
Foliar Sprays Hold the Highest Share of the Market
Based on the proprietary market report, Foliar sprays hold highest application share, owing to rapid, targeted delivery that integrates easily into existing spray programs. This targeted approach allows growers to rapidly correct acute nutrient deficiencies or address sudden pest and disease outbreaks in real-time, preventing severe yield drag.
On the other hand, seed treatments segment is likely to grow at a higher CAGR during the forecast period. This growth is driven by a shift toward preventive and input-efficient crop establishment strategies. Rather than relying on reactive, broad-acre foliar applications, modern agricultural systems are prioritizing localized, seed-applied solutions. This targeted approach ensures maximum early-stage protection against soil-borne pathogens and pests while drastically reducing chemical runoff, aligning operational efficiency with tightening environmental ESG standards.
Cereals and Pulses Dominate the Crop Treating Segment
Based on the Roots Analysis market report, cereals and pulses account for the highest overall market share. This highest share is driven by the sheer scale of global cultivation area and government-backed soil-health initiatives such as ICAR-CRIDA's Save the Field Campaign (Khet Bachao Abhiyan), launched in June.
On the other hand, fruits and nuts are projected to grow at the fastest CAGR during the forecast period. This rapid growth is propelled by escalating export-compliance demands and the lucrative per-acre margins in high-value horticulture, which make growers far more receptive to investing in premium biological solutions.
North America Dominates the Market and Registers Higher CAGR
North America anchors the global market, driven by a mature organic-farming infrastructure, high biological adoption rates, and robust commercial distribution channels. This dominance is further stabilized by the EPA's structured regulatory frameworks, which provide clear, predictable registration pathways for novel crop inputs.
Meanwhile, the Asia-Pacific region is projected to register the fastest CAGR during the forecast period till 2035. This highest growth is propelled by aggressive government-backed soil restoration mandates and a massive domestic push to scale manufacturing capacity in agricultural giant countries like India and China, paving the way for rapid localized production of advanced crop solutions.
Example Players in Agricultural Biologicals Market
• AMVAC
• Andermatt
• BASF
• Bayer
• BioSafe Systems
• Brandt
• Certis Biologicals
• Corteva Agriscience
• FBSciences
• Grow Indigo
• Koppert Biological Systems
• Lallemand
• Nutri-Tech Solutions
• Novonesis
• PI Industries
• ProFarm
• SQM
• Stoller
• Syngenta AG
• UPL
• Vegalab
• Valent Biosciences
• Verdisian Life Sciences
Expert Interview and Industry Insights
The opinions and insights presented in this study were shaped by discussions with multiple stakeholders across the value chain. The research report features detailed transcripts of interviews held with the following industry participants:
• President, Mid-sized Company, Switzerland
• Global Director, Mid-sized Company, Canada
• Sales Representative, Mid-sized Company, China
In addition, the market report includes transcripts of the following other third-party discussions:
• Chairman of the Board, Mid-sized Company, US
• Head of Biologics, Very Large Company, Germany
• Agribusiness Strategist, Small Company, Brazil
• Director of Market Innovation, Mid-sized Company, US
• Chief Executive Officer and Co-founder, Mid-sized Company, Belgium
• Director of Technical Marketing and Communication, Mid-sized Company, US
• Head of Crop Protection Product Team Biologicals, Very Large Company, Germany
• Founder and Former Chief Executive Officer, Mid-sized Company, US
• Chief Executive Officer and President, Mid-sized Company, Spain
• Co-founder and Chief Executive Officer, Mid-sized Company, Chile
AGRICULTURAL BIOLOGICALS MARKET: RESEARCH COVERAGE
• Market Sizing and Opportunity Analysis: An in-depth analysis of the agricultural biologicals market, focusing on key segments, including type of product, source of product, mode of application, type of crop treated, and geographical regions.
• Distributor and Channel Landscape: A dedicated view of how application method (foliar, seed, soil) and crop-cycle seasonality shape inventory, cold-chain and last-mile distribution requirements, directly relevant to distributors and agri-input retailers.
• Developer Landscape: A detailed assessment of companies developing agricultural biologicals, based on parameters such as year of establishment, company size, location of headquarters, and product portfolio breadth.
• Company Profiles: In-depth profiles of prominent players engaged in the development and commercialization of agricultural biologicals, featuring information on year of establishment, headquarters, product portfolio, and key initiatives.
• Partnerships and Collaborations Analysis: A comprehensive assessment of partnership activity among agricultural biologicals developers, evaluated by year, partnership type, focus area, and geography, highlighting the most active companies and regional deal patterns.
• Patent Analysis: A comprehensive analysis of patents related to agricultural biologicals, based on several relevant parameters, including publication year, application year, patent type, jurisdiction, CPC symbols, and type of applicant. The chapter further presents an assessment of the leading industry players, non-industry players, and individual assignees based on patent activity.
• Porter’s Five Forces Analysis: A qualitative assessment of the competitive dynamics within the market using Porter’s Five Forces framework. The chapter evaluates the impact of five key forces, namely, the threat of new entrants, bargaining power of end-users, bargaining power of product developers, threat of substitute products, and rivalry among existing competitors, providing insights into the overall attractiveness, competitive intensity, and long-term growth potential of the market.
• Market Impact Analysis: The report analyzes drivers, restraints, opportunities, and challenges affecting market growth, including the impact of regulatory fragmentation on biostimulant commercialization.
Key Questions Answered in this Report
• How large is the agricultural biologicals market today, and how large will it be by 2035?
• Which product types, sources and application modes are gaining or losing share?
• Which companies are best positioned across each segment, and how deep is their product pipeline?
• How will the shift toward biofertilizers and seed treatments reshape distribution and channel economics?
• Which crop segments and geographies offer the strongest near-term revenue and long-term growth combination?
• What is the realistic impact of regulatory fragmentation on biostimulant commercialization timelines?
Reasons to Buy this Report
Market players evaluating the agricultural biologicals opportunity need more than a headline market size. This report is built to support commercial decision-making, not just awareness, and differentiates itself on the following counts:
• Top-Down and Bottom-Up Triangulated Forecasting: Revenue projections for each segment are cross-validated using both macro-level agronomic demand data and company-level sales figures, reducing forecast risk for investors and channel partners.
• Primary Research with Senior Commercial and Technical Leadership: Insights are grounded in interviews with presidents, global directors, and heads of biologics across large, mid-sized, and specialty organizations, not desk research alone.
• Distribution and Channel-Specific Lens: Unlike generic agri-input market reports, this study maps how the mix shift across foliar, seed, and soil application methods will change storage stability requirements, seasonal inventory planning, and retail agri-input accessibility, insights directly relevant to distributors and input retailers.
• Regulatory-Readiness Analysis: A dedicated view of EPA and EFSA treatment of biopesticides versus the fragmented, evolving oversight of biostimulants helps distributors time market-entry and portfolio decisions around regulatory clarity.
• Investor-Grade Financial Context: Company profiles include revenue trends, recent capital deployment (such as IPL Biologicals' expanded manufacturing capacity and BASF's AgBiTech acquisition), and funding activity, positioned for use in diligence and business case development.
Additional Benefits
• Complementary PPT Insights Pack
• Complementary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older
目錄 Table of Contents
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross Border Dynamics
4.3. Conclusion
5. EXECUTIVE SUMMARY
5.1. Executive Summary: Market Landscape
5.2. Executive Summary: Market Trends
5.3. Executive Summary: Market Forecast and Opportunity Analysis
6. INTRODUCTION
6.1. Chapter Overview
6.2. Sustainable Agriculture
6.3. Introduction to Agricultural Biologicals
6.3.1. Types of Agricultural Biologicals
6.3.1.1. Biostimulants
6.3.1.2. Biopesticides / Biocontrol
6.3.1.3. Biofertilizers
6.3.2. Advantages of Agricultural Biologicals
6.4. Future Perspectives
7. MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Agricultural Biologicals Manufacturers: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Year of Establishment and Company Size
7.2.4. Analysis by Location of Headquarters
7.2.5. Analysis by Company Size and Location of Headquarters
7.2.6. Analysis by Type of Product Offered
7.2.7. Analysis by Company Size and Type of Product Offered
7.2.8. Analysis by Source of Product Offered
7.2.9. Analysis by Type of Product Formulation
7.2.10. Analysis by Type of Crop Treated
7.2.11. Analysis by Mode of Application
7.2.12. Analysis by Number of Products Offered
7.2.13. Most Active Players: Analysis by Number of Products Offered
8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in North America
8.4.1. Very Small and Small Companies in North America
8.4.2. Mid-sized Companies in North America
8.4.3. Large and Very Large Companies in North America
8.5. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in Europe
8.5.1. Very Small and Small Companies in Europe
8.5.2. Mid-sized Companies in Europe
8.5.3. Large and Very Large Companies in Europe
8.6. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in Asia-Pacific and Rest of the World
8.6.1. Very Small and Small Companies in Asia-Pacific and Rest of the World
8.6.2. Mid-sized Companies in Asia-Pacific and Rest of the World
8.6.3. Large and Very Large Companies in Asia-Pacific and Rest of the World
8.7. Company Competitiveness Analysis: Other Agricultural Biologicals Manufacturers
9. COMPANY PROFILES
9.1. Chapter Overview
9.2. Leading Players in Agricultural Biologicals Market
9.2.1. Andermatt
9.2.1.1. Company Overview
9.2.1.2. Agricultural Biologicals Portfolio
9.2.1.3. Recent Developments and Future Outlook
9.2.2. Certis Biologicals
9.2.2.1. Company Overview
9.2.2.2. Agricultural Biologicals Portfolio
9.2.2.3. Recent Developments and Future Outlook
9.2.3. Corteva Agriscience
9.2.3.1. Company Overview
9.2.3.2. Financial Information
9.2.3.3. Agricultural Biologicals Portfolio
9.2.3.4. Recent Developments and Future Outlook
9.2.4. Nutri-Tech Solutions
9.2.4.1. Company Overview
9.2.4.2. Agricultural Biologicals Portfolio
9.2.4.3. Recent Developments and Future Outlook
9.2.5. Novozymes
9.2.5.1. Company Overview
9.2.5.2. Financial Information
9.2.5.3. Agricultural Biologicals Portfolio
9.2.5.4. Recent Developments and Future Outlook
9.2.6. ProFarm
9.2.6.1. Company Overview
9.2.6.2. Agricultural Biologicals Portfolio
9.2.6.3. Recent Developments and Future Outlook
9.2.7. SQM
9.2.7.1. Company Overview
9.2.7.2. Agricultural Biologicals Portfolio
9.2.7.3. Recent Developments and Future Outlook
9.2.8. UPL
9.2.8.1. Company Overview
9.2.8.2. Financial Information
9.2.8.3. Agricultural Biologicals Portfolio
9.2.8.4. Recent Developments and Future Outlook
9.2.9. Vegalab
9.2.9.1. Company Overview
9.2.9.2. Agricultural Biologicals Portfolio
9.2.9.3. Recent Developments and Future Outlook
9.3. Other Leading Players in Agricultural Biologicals Market
9.3.1. AMVAC
9.3.1.1. Company Overview
9.3.1.2. Agricultural Biologicals Portfolio
9.3.2. BASF
9.3.2.1. Company Overview
9.3.2.2. Agricultural Biologicals Portfolio
9.3.3. Bayer
9.3.3.1. Company Overview
9.3.3.2. Agricultural Biologicals Portfolio
9.3.4. BioSafe Systems
9.3.4.1. Company Overview
9.3.4.2. Agricultural Biologicals Portfolio
9.3.5. Brandt
9.3.5.1. Company Overview
9.3.5.2. Agricultural Biologicals Portfolio
9.3.6. Chr.
9.3.6.1. Company Overview
9.3.6.2. Agricultural Biologicals Portfolio
9.3.7. FBSciences
9.3.7.1. Company Overview
9.3.7.2. Agricultural Biologicals Portfolio
9.3.8. Grow Indigo
9.3.8.1. Company Overview
9.3.8.2. Agricultural Biologicals Portfolio
9.3.9. Koppert
9.3.9.1. Company Overview
9.3.9.2. Agricultural Biologicals Portfolio
9.3.10. Lallemand
9.3.10.1. Company Overview
9.3.10.2. Agricultural Biologicals Portfolio
9.3.11. PI Industries
9.3.11.1. Company Overview
9.3.11.2. Agricultural Biologicals Portfolio
9.3.12. Stoller
9.3.12.1. Company Overview
9.3.12.2. Agricultural Biologicals Portfolio
9.3.13. Syngenta
9.3.13.1. Company Overview
9.3.13.2. Agricultural Biologicals Portfolio
9.3.14. Valent Biosciences
9.3.14.1. Company Overview
9.3.14.2. Agricultural Biologicals Portfolio
9.3.15. Verdesian Life Sciences
9.3.15.1. Company Overview
9.3.15.2. Agricultural Biologicals Portfolio
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Agricultural Biologicals: Recent Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Analysis by Type of Partnership and Company Size
10.3.5. Analysis by Focus Area of Partnership
10.3.6. Analysis by Type of Partner
10.3.7. Most Active Players: Analysis by Number of Partnerships
10.3.8. Analysis by Geography
10.3.8.1. Local and International Agreements
10.3.8.2. Intracontinental and Intercontinental Agreements
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Agricultural Biologicals: Patent Analysis
11.3.1. Analysis by Patent Publication Year
11.3.2. Analysis by Patent Application Year
11.3.3. Analysis of Granted Patents and Patent Applications by Publication Year
11.3.4. Analysis by Patent Jurisdiction
11.3.5. Analysis by CPC Symbols
11.3.6. Analysis by Type of Applicant
11.3.7. Leading Industry Players: Analysis by Number of Patents
11.3.8. Leading Non-Industry Players: Analysis by Number of Patents
11.3.9. Leading Individual Assignees: Analysis by Number of Patents
11.4. Agricultural Biologicals: Patent Benchmarking Analysis
11.4.1. Analysis by Patent Characteristics
11.5. Agricultural Biologicals: Patent Valuation
11.6. Leading Patents by Number of Citations
12. PORTER’S FIVE FORCES ANALYSIS
12.1. Chapter Overview
12.2. Methodology and Assumptions
12.3. Key Parameters
12.3.1. Threats of New Entrants
12.3.2. Bargaining Power of End-Users
12.3.3. Bargaining Power of Product Developers
12.3.4. Threats of Substitute Products
12.3.5. Rivalry Among Existing Competitors
12.4. Concluding Remarks
13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
13.1. Chapter Overview
13.2. Market Drivers
13.3. Market Restraints
13.4. Market Opportunities
13.5. Market Challenges
13.6. Conclusion
14. GLOBAL AGRICULTURAL BIOLOGICALS MARKET
14.1. Chapter Overview
14.2. Assumptions and Methodology
14.3. Global Agricultural Biologicals Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.3.1. Scenario Analysis
14.4. Key Market Segmentations
14.5. Dynamic Dashboard
15. AGRICULTURAL BIOLOGICALS MARKET, BY TYPE OF PRODUCT
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Agricultural Biologicals Market: Distribution by Type of Product (USD Billion)
15.3.1. Biopesticides / Biocontrol Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
15.3.2. Biofertilizers Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
15.3.3. Biostimulants Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
15.4. Data Triangulation
15.4.1. Insights based on Primary Research
15.4.2. Insights based on Secondary Research
16. AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE OF PRODUCT
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Agricultural Biologicals Market: Distribution by Source of Product (USD Billion)
16.3.1. Agricultural Biologicals Market for Microbes: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
16.3.2. Agricultural Biologicals Market for Plant Extracts: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
16.3.3. Agricultural Biologicals Market for Other Sources: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
16.4. Data Triangulation
16.4.1. Insights based on Primary Research
16.4.2. Insights based on Secondary Research
17. AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Agricultural Biologicals Market: Distribution by Mode of Application (USD Billion)
17.3.1. Agricultural Biologicals Market for Foliar Sprays: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
17.3.2. Agricultural Biologicals Market for Seed Treatments: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
17.3.3. Agricultural Biologicals Market for Soil Treatments: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
17.3.4. Agricultural Biologicals Market for Other Application Methods: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
17.4. Data Triangulation
17.4.1. Insights based on Primary Research
17.4.2. Insights based on Secondary Research
18. AGRICULTURAL BIOLOGICALS MARKET, BY TYPE OF CROP TREATED
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Agricultural Biologicals Market: Distribution by Type of Crop Treated (USD Billion)
18.3.1. Agricultural Biologicals Market for Cereals and Pulses: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
18.3.2. Agricultural Biologicals Market for Fruits and Nuts: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
18.3.3. Agricultural Biologicals Market for Oilseeds: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
18.3.4. Agricultural Biologicals Market for Green Fodder, Vegetables and Tubers: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
18.3.5. Agricultural Biologicals Market for Industrial Crops, Textile Crops and Others: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
18.4. Data Triangulation
18.4.1. Insights based on Secondary Research
19. AGRICULTURAL BIOLOGICALS MARKET, BY GEOGRAPHY
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Agricultural Biologicals Market: Distribution by Key Geographical Regions (USD Billion)
19.3.1. Agricultural Biologicals Market for North America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
19.3.2. Agricultural Biologicals Market for Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
19.3.3. Agricultural Biologicals Market for Asia-Pacific: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
19.3.4. Agricultural Biologicals Market for Latin America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
19.3.5. Agricultural Biologicals Market for Middle East and North Africa: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
19.4. Data Triangulation
19.4.1. Insights based on Primary Research
19.4.2. Insights based on Secondary Research
20. CONCLUSION
21. EXECUTIVE INSIGHTS
21.1. Company A
21.1.1. Company Overview
21.1.2. Interview Transcript: President
21.2. Company B
21.2.1. Company Overview
21.2.2. Interview Transcript: Global Director
21.3. Company C
21.3.1. Company Overview
21.3.2. Interview Transcript: Sales Representative
21.4. Company D
21.4.1. Company Overview
21.4.2. Interview Transcript: Chairman of the Board
21.5. Company E
21.5.1. Company Overview
21.5.2. Interview Transcript: Head of Biologics
21.6. Company F
21.6.1. Company Overview
21.6.2. Interview Transcript: Agribusiness Strategist
21.7. Company G
21.7.1. Company Overview
21.7.2. Interview Transcript: Director of Market Innovation
21.8. Company H
21.8.1. Company Overview
21.8.2. Interview Transcript: Chief Executive Officer and Co-founder
21.9. Company I
21.9.1. Company Overview
21.9.2. Interview Transcript: Director of Technical Marketing and Communication
21.10. Company J
21.10.1. Company Overview
21.10.2. Interview Transcript: Head of Crop Protection Product Team Biologicals
21.11. Company K
21.11.1. Company Overview
21.11.2. Interview Transcript: Founder and Former Chief Executive Officer
21.12. Company L
21.12.1. Company Overview
21.12.2. Interview Transcript: Chief Executive Officer and President
21.13. Company M
21.13.1. Company Overview
21.13.2. Interview Transcript: Co-founder and Chief Executive Officer
22. APPENDIX 1: TABULATED DATA
圖表清單 List of Tables & Figures
Table 6.1 List of Agricultural Biological Manufacturers
Table 6.2 Agricultural Biological Manufacturers: Information on Type of Product Offered
Table 6.3 Agricultural Biological Manufacturers: Information on Number of Products Offered, Source of Product Offered and Type of Product Formulation
Table 6.4 Agricultural Biological Manufacturers: Information on Type of Crop Treated
Table 6.5 Agricultural Biological Manufacturers: Information on Mode of Application
Table 8.1 Agricultural Biological Providers: List of Companies Profiled
Table 8.2 Andermatt: Company Overview
Table 8.3 Andermatt: Agricultural Biologicals Portfolio
Table 8.4 Andermatt: Recent Developments and Future Outlook
Table 8.5 Certis Biologicals: Company Overview
Table 8.6 Certis Biologicals: Agricultural Biologicals Portfolio
Table 8.7 Certis Biologicals: Recent Developments and Future Outlook
Table 8.8 Corteva Agriscience: Company Overview
Table 8.9 Corteva Agriscience: Agricultural Biologicals Portfolio
Table 8.10 Corteva Agriscience: Recent Developments and Future Outlook
Table 8.11 Nutri-Tech Solutions: Company Overview
Table 8.12 Nutri-Tech Solutions: Agricultural Biologicals Portfolio
Table 8.13 Novozymes: Company Overview
Table 8.14 Novozymes: Agricultural Biologicals Portfolio
Table 8.15 Novozymes: Recent Developments and Future Outlook
Table 8.16 ProFarm: Company Overview
Table 8.17 ProFarm: Agricultural Biologicals Portfolio
Table 8.18 ProFarm: Recent Developments and Future Outlook
Table 8.19 SQM: Company Overview
Table 8.20 SQM: Agricultural Biologicals Portfolio
Table 8.21 SQM: Recent Developments and Future Outlook
Table 8.22 UPL: Company Overview
Table 8.23 UPL: Agricultural Biologicals Portfolio
Table 8.24 UPL: Recent Developments and Future Outlook
Table 8.25 Vegalab: Company Overview
Table 8.26 Vegalab: Agricultural Biologicals Portfolio
Table 8.27 AMVAC: Company Overview
Table 8.28 AMVAC: Agricultural Biologicals Portfolio
Table 8.29 BASF: Company Overview
Table 8.30 BASF: Agricultural Biologicals Portfolio
Table 8.31 Bayer: Company Overview
Table 8.32 Bayer: Agricultural Biologicals Portfolio
Table 8.33 BioSafe Systems: Company Overview
Table 8.34 BioSafe Systems: Agricultural Biologicals Portfolio
Table 8.35 Brandt: Company Overview
Table 8.36 Brandt: Agricultural Biologicals Portfolio
Table 8.37 Chr. Hansen: Company Overview
Table 8.38 Chr. Hansen: Agricultural Biologicals Portfolio
Table 8.39 FBSciences: Company Overview
Table 8.40 FBSciences: Agricultural Biologicals Portfolio
Table 8.41 Grow Indigo: Company Overview
Table 8.42 Grow Indigo: Agricultural Biologicals Portfolio
Table 8.43 Koppert: Company Overview
Table 8.44 Koppert: Agricultural Biologicals Portfolio
Table 8.45 Lallemand: Company Overview
Table 8.46 Lallemand: Agricultural Biologicals Portfolio
Table 8.47 PI Industries: Company Overview
Table 8.48 PI Industries: Agricultural Biologicals Portfolio
Table 8.49 Stoller: Company Overview
Table 8.50 Stoller: Agricultural Biologicals Portfolio
Table 8.51 Syngenta: Company Overview
Table 8.52 Syngenta: Agricultural Biologicals Portfolio
Table 8.53 Valent Biosciences: Company Overview
Table 8.54 Valent Biosciences: Agricultural Biologicals Portfolio
Table 8.55 Verdisian Life Sciences: Company Overview
Table 8.56 Verdisian Life Sciences: Agricultural Biologicals Portfolio
Table 9.1 Agricultural Biologicals Market: List of Partnerships and Collaborations, Since 2020
Table 10.1 Patent Analysis: Top CPC Sections
Table 10.2 Patent Analysis: Top CPC Symbols
Table 10.3 Patent Analysis: Top CPC Codes
Table 10.4 Patent Analysis: Summary of Benchmarking Analysis
Table 10.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 10.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 10.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 20.1 Vegalab: Company Snapshot
Table 20.2 Acadian Plant Health: Company Snapshot
Table 20.3 Jiahe Biology: Company Snapshot
Table 21.1 Agricultural Biologicals Manufacturers: Distribution by Year of Establishment
Table 21.2 Agricultural Biological Manufacturers: Distribution by Company Size
Table 21.3 Agricultural Biological Manufacturers: Distribution by Year of Establishment and Company Size
Table 21.4 Agricultural Biological Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 21.5 Agricultural Biological Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 21.6 Agricultural Biological Manufacturers: Distribution by Company Size and Location of Headquarters (Region-wise)
Table 21.7 Agricultural Biological Manufacturers: Distribution by Type of Product Offered
Table 21.8 Agricultural Biological Manufacturers: Distribution by Type of Biostimulant Offered
Table 21.9 Agricultural Biological Manufacturers: Distribution by Type of Biopesticide / Biocontrol Offered
Table 21.10 Agricultural Biological Manufacturers: Distribution by Type of Biofertilizer Offered
Table 21.11 Agricultural Biological Manufacturers: Distribution by Company Size and Type of Product Offered
Table 21.12 Agricultural Biological Manufacturers: Distribution by Source of Product Offered
Table 21.13 Agricultural Biological Manufacturers: Distribution by Type of Product Formulation
Table 21.14 Agricultural Biological Manufacturers: Distribution by Type of Crop Treated
Table 21.15 Agricultural Biological Manufacturers: Distribution by Mode of Application
Table 21.16 Agricultural Biological Manufacturers: Distribution by Number of Products Offered
Table 21.17 Most Active Players: Distribution by the Number of Products Offered
Table 21.18 Corteva Agriscience: Annual Revenues, Since FY 2019 (USD Million)
Table 21.19 Novozymes: Annual Revenues, Since FY 2019 (DKK Million)
Table 21.20 UPL: Annual Revenues, Since FY 2019 (INR Crore)
Table 21.21 Partnerships and Collaborations: Distribution by Year of Partnership, Since 2020
Table 21.22 Partnerships and Collaborations: Distribution by Type of Partnership
Table 21.23 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 21.24 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Table 21.25 Partnerships and Collaborations: Distribution by Focus Area of Partnerships
Table 21.26 Partnerships and Collaborations: Distribution by Type of Partner
Table 21.27 Most Active Players: Distribution by Number of Partnerships
Table 21.28 Partnerships and Collaborations: Local and International Agreements
Table 21.29 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Table 21.30 Patent Analysis: Distribution by Type of Patent
Table 21.31 Patent Analysis: Distribution by Patent Publication Year, Since 2019
Table 21.32 Patent Analysis: Distribution by Patent Application Year, Since Pre-2015
Table 21.33 Patent Analysis: Distribution of Granted Patents and Patent Applications by Publication Year, Since 2019
Table 21.34 Patent Analysis: Distribution by Patent Jurisdiction (Region-wise)
Table 21.35 Patent Analysis: Distribution by Patent Jurisdiction (Country-wise)
Table 21.36 Patent Analysis: Distribution by CPC Symbols
Table 21.37 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant, Since 2019
Table 21.38 Leading Industry Players: Distribution by Number of Patents
Table 21.39 Leading Non-Industry Players: Distribution by Number of Patents
Table 21.40 Leading Individual Assignees: Distribution by Number of Patents
Table 21.41 Patent Benchmarking Analysis: Distribution of Leading Industry Player by Patent Characteristics (CPC Codes)
Table 21.42 Patent Analysis: Distribution by Patent Age
Table 21.43 Agricultural Biologicals: Patent Valuation
Table 21.44 Global Agricultural Biologicals Market, Historical Trends (Since 2019) (USD Billion)
Table 21.45 Global Agricultural Biologicals Market, Forecasted Estimates (Till 2035): Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.46 Agricultural Biologicals Market: Distribution by Type of Product (USD Billion)
Table 21.47 Biopesticides / Biocontrol Market: Historical Trends (Since 2019) (USD Billion)
Table 21.48 Biopesticides / Biocontrol Market: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.49 Biofertilizers Market: Historical Trends (Since 2019) (USD Billion)
Table 21.50 Biofertilizers Market: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.51 Biostimulants Market: Historical Trends (Since 2019) (USD Billion)
Table 21.52 Biostimulants Market: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.53 Agricultural Biologicals Market: Distribution by Source of Product (USD Billion)
Table 21.54 Agricultural Biologicals Market for Microbes: Historical Trends (Since 2019) (USD Billion)
Table 21.55 Agricultural Biologicals Market for Microbes: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.56 Agricultural Biologicals Market for Plant Extracts: Historical Trends (Since 2019) (USD Billion)
Table 21.57 Agricultural Biologicals Market for Plant Extracts: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.58 Agricultural Biologicals Market for Other Sources: Historical Trends (Since 2019) (USD Billion)
Table 21.59 Agricultural Biologicals Market for Other Sources: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.60 Agricultural Biologicals Market: Distribution by Mode of Application (USD Billion)
Table 21.61 Agricultural Biologicals Market for Foliar Sprays: Historical Trends (Since 2019) (USD Billion)
Table 21.62 Agricultural Biologicals Market for Foliar Sprays: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.63 Agricultural Biologicals Market for Seed Treatments: Historical Trends (Since 2019) (USD Billion)
Table 21.64 Agricultural Biologicals Market for Seed Treatments: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.65 Agricultural Biologicals Market for Soil Treatments: Historical Trends (Since 2019) (USD Billion)
Table 21.66 Agricultural Biologicals Market for Soil Treatments: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.67 Agricultural Biologicals Market for Other Application Methods: Historical Trends (Since 2019) (USD Billion)
Table 21.68 Agricultural Biologicals Market for Other Application Methods: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.69 Agricultural Biologicals Market: Distribution by Type of Crop Treated (USD Billion)
Table 21.70 Agricultural Biologicals Market for Cereals and Pulses: Historical Trends (Since 2019) (USD Billion)
Table 21.71 Agricultural Biologicals Market for Cereals and Pulses: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.72 Agricultural Biologicals Market for Fruits and Nuts: Historical Trends (Since 2019) (USD Billion)
Table 21.73 Agricultural Biologicals Market for Fruits and Nuts: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.74 Agricultural Biologicals Market for Oilseeds: Historical Trends (Since 2019) (USD Billion)
Table 21.75 Agricultural Biologicals Market for Oilseeds: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.76 Agricultural Biologicals Market for Green Fodder, Vegetables and Tubers: Historical Trends (Since 2019) (USD Billion)
Table 21.77 Agricultural Biologicals Market for Green Fodder, Vegetables and Tubers: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.78 Agricultural Biologicals Market for Industrial Crops, Textile Crops and Others: Historical Trends (Since 2019) (USD Billion)
Table 21.79 Agricultural Biologicals Market for Industrial Crops, Textile Crops and Others: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.80 Agricultural Biologicals Market: Distribution by Key Geographical Regions (USD Billion)
Table 21.81 Agricultural Biologicals Market for North America: Historical Trends (Since 2019) (USD Billion)
Table 21.82 Agricultural Biologicals Market for North America: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.83 Agricultural Biologicals Market for Europe: Historical Trends (Since 2019) (USD Billion)
Table 21.84 Agricultural Biologicals Market for Europe: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.85 Agricultural Biologicals Market for Asia-Pacific: Historical Trends (Since 2019) (USD Billion)
Table 21.86 Agricultural Biologicals Market for Asia-Pacific: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.87 Agricultural Biologicals Market for Latin America: Historical Trends (Since 2019) (USD Billion)
Table 21.88 Agricultural Biologicals Market for Latin America: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.89 Agricultural Biologicals Market for Middle East and North Africa: Historical Trends (Since 2019) (USD Billion)
Table 21.90 Agricultural Biologicals Market for Middle East and North Africa: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Figure 2.1 Research Methodology: Research Assumptions
Figure 2.2 Research Methodology: Project Methodology
Figure 2.3 Research Methodology: Forecast Methodology
Figure 2.4 Research Methodology: Robust Quality Control
Figure 2.5 Research Methodology: Key Market Segmentations
Figure 3.1 Lessons Learnt from Past Recessions
Figure 4.1 Executive Summary: Agricultural Biologicals Market Landscape
Figure 4.2 Executive Summary: Partnerships and Collaborations
Figure 4.3 Executive Summary: Patent Analysis
Figure 4.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Differences between Conventional and Sustainable Agricultural Practices
Figure 5.2 Types of Agricultural Biologicals
Figure 5.3 Types of Biostimulants
Figure 5.4 Types of Biopesticides
Figure 5.5 Types of Biofertilizers
Figure 5.6 Advantages of Agricultural Biologicals
Figure 6.1 Agricultural Biological Manufacturers: Distribution by Year of Establishment
Figure 6.2 Agricultural Biological Manufacturers: Distribution by Company Size
Figure 6.3 Agricultural Biological Manufacturers: Distribution by Year of Establishment and Company Size
Figure 6.4 Agricultural Biological Manufacturers: Distribution by Location of Headquarters (Region)
Figure 6.5 Agricultural Biological Manufacturers: Distribution by Location of Headquarters (Country)
Figure 6.6 Agricultural Biological Manufacturers: Distribution by Company Size and Location of Headquarters (Region)
Figure 6.7 Agricultural Biological Manufacturers: Distribution by Type of Product Offered
Figure 6.8 Agricultural Biological Manufacturers: Distribution by Type of Biostimulant Offered
Figure 6.9 Agricultural Biological Manufacturers: Distribution by Type of Biopesticide / Biocontrol Offered
Figure 6.10 Agricultural Biological Manufacturers: Distribution by Type of Biofertilizer Offered
Figure 6.11 Agricultural Biological Manufacturers: Distribution by Company Size and Type of Product Offered
Figure 6.12 Agricultural Biological Manufacturers: Distribution by Source of Product Offered
Figure 6.13 Agricultural Biological Manufacturers: Distribution by Type of Product Formulation
Figure 6.14 Agricultural Biological Manufacturers: Distribution by Type of Crop Treated
Figure 6.15 Agricultural Biological Manufacturers: Distribution by Mode of Application
Figure 6.16 Agricultural Biological Manufacturers: Distribution by Number of Products Offered
Figure 6.17 Most Active Players: Distribution by the Number of Products Offered
Figure 7.1 Company Competitiveness Analysis: Very Small and Small Companies in North America
Figure 7.2 Company Competitiveness Analysis: Mid-sized Companies in North America
Figure 7.3 Company Competitiveness Analysis: Large and Very Large Companies in North America
Figure 7.4 Company Competitiveness Analysis: Very Small and Small Companies in Europe
Figure 7.5 Company Competitiveness Analysis: Mid-Sized Companies in Europe
Figure 7.6 Company Competitiveness Analysis: Large and Very Large Companies in Europe
Figure 7.7 Company Competitiveness Analysis: Very Small and Small Companies in Asia-Pacific and Rest of the World
Figure 7.8 Company Competitiveness Analysis: Mid-sized Companies in Asia-Pacific and Rest of the World
Figure 7.9 Company Competitiveness Analysis: Large and Very Large Companies in Asia-Pacific and Rest of the World
Figure 7.10 Company Competitiveness Analysis: Other Agricultural Biological Manufacturers
Figure 8.1 Corteva Agriscience: Annual Revenues, Since FY 2019 (USD Million)
Figure 8.2 Novozymes: Annual Revenues, Since FY 2019 (DKK Million)
Figure 8.3 UPL: Annual Revenues, Since FY 2019 (INR Crore)
Figure 9.1 Partnerships and Collaborations: Distribution by Year of Partnership, Since 2020
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Figure 9.5 Partnerships and Collaborations: Distribution by Focus Area of Partnerships
Figure 9.6 Partnerships and Collaborations: Distribution by Type of Partner
Figure 9.7 Most Active Players: Distribution by Number of Partnerships
Figure 9.8 Partnerships and Collaborations: Local and International Agreements
Figure 9.9 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 10.1 Patent Analysis: Distribution by Type of Patent
Figure 10.2 Patent Analysis: Distribution by Patent Publication Year, Since 2019
Figure 10.3 Patent Analysis: Distribution by Patent Application Year, Since Pre-2015
Figure 10.4 Patent Analysis: Distribution of Granted Patents and Patent Applications by Publication Year, Since 2019
Figure 10.5 Patent Analysis: Distribution by Patent Jurisdiction (Region-wise)
Figure 10.6 Patent Analysis: Distribution by Patent Jurisdiction (Country-wise)
Figure 10.7 Patent Analysis: Distribution by CPC Symbols
Figure 10.8 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant, Since 2019
Figure 10.9 Leading Industry Players: Distribution by Number of Patents
Figure 10.10 Leading Non-Industry Players: Distribution by Number of Patents
Figure 10.11 Leading Individual Assignees: Distribution by Number of Patents
Figure 10.12 Patent Benchmarking Analysis: Distribution of Leading Industry Player by Patent Characteristics (CPC Codes)
Figure 10.13 Patent Analysis: Distribution by Patent Age
Figure 10.14 Agricultural Biologicals: Patent Valuation
Figure 11.1 Porter’s Five Forces: Key Parameters
Figure 11.2 Threats of New Entrants: Key Factors
Figure 11.3 Bargaining Power of End-Users: Key Factors
Figure 11.4 Bargaining Power of Product Developers: Key Factors
Figure 11.5 Threats of Substitute Products: Key Factors
Figure 11.6 Rivalry Among Existing Competitors: Key Factors
Figure 11.7 Porter’s Five Forces: Concluding Remarks
Figure 12.1 Market Impact Analysis: Drivers, Restraints, Opportunities and Challenges
Figure 13.1 Global Agricultural Biologicals Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035): Base Scenario (USD Billion)
Figure 13.2 Global Agricultural Biologicals Market, Forecasted Estimates (Till 2035), Conservative Scenario (USD Billion)
Figure 13.3 Global Agricultural Biologicals Market, Forecasted Estimates (Till 2035), Optimistic Scenario (USD Billion)
Figure 14.1 Agricultural Biologicals Market: Distribution by Type of Product (USD Billion)
Figure 14.2 Biopesticides / Biocontrol Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 14.3 Biofertilizers Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 14.4 Biostimulants Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 15.1 Agricultural Biologicals Market: Distribution by Source of Product (USD Billion)
Figure 15.2 Agricultural Biologicals Market for Microbes: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 15.3 Agricultural Biologicals Market for Plant Extracts: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 15.4 Agricultural Biologicals Market for Other Sources: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.1 Agricultural Biologicals Market: Distribution by Mode of Application (USD Billion)
Figure 16.2 Agricultural Biologicals Market for Foliar Sprays: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.3 Agricultural Biologicals Market for Seed Treatments: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.4 Agricultural Biologicals Market for Soil Treatments: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.5 Agricultural Biologicals Market for Other Application Methods: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.1 Agricultural Biologicals Market: Distribution by Type of Crop Treated (USD Billion)
Figure 17.2 Agricultural Biologicals Market for Cereals and Pulses: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.3 Agricultural Biologicals Market for Fruits and Nuts: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.4 Agricultural Biologicals Market for Oilseeds: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.5 Agricultural Biologicals Market for Green Fodder, Vegetables and Tubers: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.6 Agricultural Biologicals Market for Industrial Crops, Textile Crops and Others: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.1 Agricultural Biologicals Market: Distribution by Key Geographical Regions (USD Billion)
Figure 18.2 Agricultural Biologicals Market for North America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.3 Agricultural Biologicals Market for Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.4 Agricultural Biologicals Market for Asia-Pacific: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.5 Agricultural Biologicals Market for Latin America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.6 Agricultural Biologicals Market for Middle East and North Africa: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.1 Conclusion: Agricultural Biologicals Market Landscape
Figure 19.2 Conclusion: Partnerships and Collaborations
Figure 19.3 Conclusion: Patent Analysis
Figure 19.4 Conclusion: Porter’s Five Forces Analysis
Figure 19.5 Conclusion: Market Forecast and Opportunity Analysis
提及公司
同分類最新報告（農業）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Roots Analysis 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們